USING THE NAME ‘REJURAN’

‘Sodium polynucleotide’ or ‘sodium DNA’ is not a substance included in Schedule 4 of the current Poisons Standard. Therefore, Rejuran can be advertised to consumers, using the trade name of the device, provided the advertisements comply with the relevant sections of the Therapeutic Goods Advertising Code and guidance from the MPAA and AHPRA.

ARTG registration for REJURAN - Dermal tissue reconstructive material, animal-derived  - ARTG ID 412630

Dermal tissue reconstructive material, animal-derived.

A sterile injectable gel containing sodium polynucleotide. Administered by injecting the gel into the dermis by a trained healthcare practitioner. The polynucleotide is hydrating to cause volumetric increases of tissues and make more favourable physiological conditions for the growth of cells in the skin.

REJURAN is an injectable gel which is intended for injection into the mid to deep dermis to promote tissue restoration and reconstruction, and improvement of physical appearance. It is highly versatile and easy to handle and can be used on areas of the face (especially around the eyes, perioral area).

https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=412630&agid=%28PrintDetailsPublic%29&actionid=1

MEDIA ENQUIRIES

Media appointments to access Rejuran are available, contact Simone for further information.

Any opinions from media must be genuine and freely given. Noting such an article would be considered advertising of a therapeutic good, it would be required to be compliant with the relevant provisions of the Therapeutic Goods Advertising Code and guidance from the MPAA and AHPRA.  Also note that consumer media MUST NOT include doctors endorsements/testimonials or quotes on Rejuran, they also must include the mandatory statement ‘Always read the label and follow directions for use’. Media can however name the treatment ‘Rejuran’’ and talk of the clinic experience. 

For more information on REJURAN® please visit https://www.rejuran.com.au

For media enquiries, contact Simone Wyndham @beautyprsydney simone@kichi.com.au

DISCLAIMER When writing or promoting Rejuran please ensure you are familiar with the TGA Advertising code and the AHPRA Guidelines. It is not the responsibility of K Bridge Medical or any of its employees or contractors to ensure your content is compliant and they will not be held liable.

Always read the label and follow directions for use.

This product is not available for purchase by the general public.